Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_provenance.
- NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_provenance.
- NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_assertion evidence source_evidence_literature NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_provenance.
- NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_assertion SIO_000772 14585279 NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_provenance.
- NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_assertion wasDerivedFrom befree-20150227 NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_provenance.
- NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_assertion wasGeneratedBy ECO_0000203 NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_provenance.